| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| APOB | APOE | ENSMMUP00000010112 | ENSMMUP00000048554 | Apolipoprotein B. | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | 0.998 |
| APOB | LRP8 | ENSMMUP00000010112 | ENSMMUP00000009997 | Apolipoprotein B. | LDL receptor related protein 8. | 0.890 |
| APOB | PCSK9 | ENSMMUP00000010112 | ENSMMUP00000007574 | Apolipoprotein B. | Proprotein convertase subtilisin/kexin type 9; Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to [...] | 0.927 |
| APOE | APOB | ENSMMUP00000048554 | ENSMMUP00000010112 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Apolipoprotein B. | 0.998 |
| APOE | LRP8 | ENSMMUP00000048554 | ENSMMUP00000009997 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | LDL receptor related protein 8. | 0.868 |
| APOE | PCSK9 | ENSMMUP00000048554 | ENSMMUP00000007574 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Proprotein convertase subtilisin/kexin type 9; Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to [...] | 0.771 |
| APOE | RELN | ENSMMUP00000048554 | ENSMMUP00000058310 | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | Reelin. | 0.493 |
| DAB1 | LRP8 | ENSMMUP00000040095 | ENSMMUP00000009997 | DAB adaptor protein 1. | LDL receptor related protein 8. | 0.950 |
| DAB1 | RELN | ENSMMUP00000040095 | ENSMMUP00000058310 | DAB adaptor protein 1. | Reelin. | 0.927 |
| DAB1 | SH3KBP1 | ENSMMUP00000040095 | ENSMMUP00000041178 | DAB adaptor protein 1. | SH3 domain containing kinase binding protein 1. | 0.930 |
| LRP8 | APOB | ENSMMUP00000009997 | ENSMMUP00000010112 | LDL receptor related protein 8. | Apolipoprotein B. | 0.890 |
| LRP8 | APOE | ENSMMUP00000009997 | ENSMMUP00000048554 | LDL receptor related protein 8. | Apolipoprotein E; APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density [...] | 0.868 |
| LRP8 | DAB1 | ENSMMUP00000009997 | ENSMMUP00000040095 | LDL receptor related protein 8. | DAB adaptor protein 1. | 0.950 |
| LRP8 | LRPAP1 | ENSMMUP00000009997 | ENSMMUP00000070649 | LDL receptor related protein 8. | LDL receptor related protein associated protein 1. | 0.773 |
| LRP8 | MAPK8IP1 | ENSMMUP00000009997 | ENSMMUP00000003307 | LDL receptor related protein 8. | Mitogen-activated protein kinase 8 interacting protein 1. | 0.778 |
| LRP8 | MAPK8IP2 | ENSMMUP00000009997 | ENSMMUP00000079930 | LDL receptor related protein 8. | Mitogen-activated protein kinase 8 interacting protein 2. | 0.778 |
| LRP8 | MYLIP | ENSMMUP00000009997 | ENSMMUP00000065793 | LDL receptor related protein 8. | E3 ubiquitin-protein ligase MYLIP. | 0.776 |
| LRP8 | PCSK9 | ENSMMUP00000009997 | ENSMMUP00000007574 | LDL receptor related protein 8. | Proprotein convertase subtilisin/kexin type 9; Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to [...] | 0.870 |
| LRP8 | RELN | ENSMMUP00000009997 | ENSMMUP00000058310 | LDL receptor related protein 8. | Reelin. | 0.986 |
| LRP8 | SH3KBP1 | ENSMMUP00000009997 | ENSMMUP00000041178 | LDL receptor related protein 8. | SH3 domain containing kinase binding protein 1. | 0.698 |
